The new plant in Kalundborg, Denmark, will double Pronova BioPharma’s production capacity. Construction work started in Q4
2007, and the plant is expected to be operational, including regulatory approval first half 2010. Total investments are expected
to be some NOK 1.45 -1.70 billion
Annual production capacity is expected to be 1 200 metric tons. The design will be modulate, with capacity for additional
two modules of 600 metric tons. Recruitment started Q1 2008, and around 85 new full time equivalents are expected to be in
place by the end of 2008
As the technology will be duplicated from the Sandefjord plant, a number of employees will be trained in Sandefjord, in order
to be prepared to operate the new plant.
